F19 25 (Dapsone 25 mg)
Pill with imprint F19 25 is White, Round and has been identified as Dapsone 25 mg. It is supplied by Fera Pharmaceuticals, LLC.
Dapsone is used in the treatment of dermatitis herpetiformis; leprosy; leprosy, lepromatous; leprosy, tuberculoid; pneumocystis pneumonia and belongs to the drug class leprostatics. Risk cannot be ruled out during pregnancy. Dapsone 25 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for F19 25
Dapsone
- Imprint
- F19 25
- Strength
- 25 mg
- Color
- White
- Size
- 6.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Leprostatics
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Fera Pharmaceuticals, LLC
- National Drug Code (NDC)
- 48102-0019
- Inactive Ingredients
-
croscarmellose sodium,
hydroxypropyl cellulose (type h),
magnesium stearate,
microcrystalline cellulose,
silicon dioxide
Note: Inactive ingredients may vary.
More about dapsone
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Compare Alternatives
- Pricing & Coupons
- En Español
- 20 Reviews
- Drug class: leprostatics
Consumer resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.